For: | Okajima W, Komatsu S, Ichikawa D, Miyamae M, Ohashi T, Imamura T, Kiuchi J, Nishibeppu K, Arita T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Okamoto K, Otsuji E. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. World J Gastroenterol 2017; 23(31): 5650-5668 [PMID: 28883691 DOI: 10.3748/wjg.v23.i31.5650] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i31/5650.htm |
Number | Citing Articles |
1 |
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188451 doi: 10.1016/j.bbcan.2020.188451
|
2 |
Annarita Perillo, Mohamed Vincenzo Agbaje Olufemi, Jacopo De Robbio, Rossella Margherita Mancuso, Anna Roscigno, Maddalena Tirozzi, Ida Rosalia Scognamiglio. Liquid biopsy in NSCLC: a new challenge in radiation therapy. Exploration of Targeted Anti-tumor Therapy 2021; doi: 10.37349/etat.2021.00038
|
3 |
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
|
4 |
Sophie Schlosser, Deniz Tümen, Barbara Volz, Katja Neumeyer, Niklas Egler, Claudia Kunst, Hauke Christian Tews, Stephan Schmid, Arne Kandulski, Martina Müller, Karsten Gülow. HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1016952
|
5 |
Jelena Mann, Helen L Reeves, Ariel E Feldstein. Liquid biopsy for liver diseases. Gut 2018; 67(12): 2204 doi: 10.1136/gutjnl-2017-315846
|
6 |
Xuenan Peng, Caifeng Gong, Wen Zhang, Aiping Zhou. Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1091088
|
7 |
Atsunori Tsuchiya, Masahiro Ogawa, Takayuki Watanabe, Suguru Takeuchi, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kazunao Hayashi, Junji Yokoyama, Shuji Terai. Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma. Heliyon 2019; 5(3): e01325 doi: 10.1016/j.heliyon.2019.e01325
|
8 |
Ning Li, Ling Li, Yongshun Chen, Hassan Obied. The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/3478305
|
9 |
Liang-Chun Yin, Zhen-Chao Luo, Yan-Xin Gao, Yang Li, Qing Peng, Yi Gao. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3789613
|
10 |
Víctor Amado, Sandra González-Rubio, Javier Zamora, Rafael Alejandre, María Lola Espejo-Cruz, Clara Linares, Marina Sánchez-Frías, Gema García-Jurado, José Luis Montero, Rubén Ciria, Manuel Rodríguez-Perálvarez, Gustavo Ferrín, Manuel De la Mata. Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation. Cancers 2021; 13(10): 2476 doi: 10.3390/cancers13102476
|
11 |
Hugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera. Liquid biopsy in chronic liver disease. Annals of Hepatology 2021; 20: 100197 doi: 10.1016/j.aohep.2020.03.008
|
12 |
Gurjot Singh, Eric M Yoshida, Sahaj Rathi, Vladimir Marquez, Peter Kim, Siegfried R Erb, Baljinder S Salh. Biomarkers for hepatocellular cancer. World Journal of Hepatology 2020; 12(9): 558-573 doi: 10.4254/wjh.v12.i9.558
|
13 |
Sinisa Bratulic, Francesco Gatto, Jens Nielsen. The Translational Status of Cancer Liquid Biopsies. Regenerative Engineering and Translational Medicine 2021; 7(3): 312 doi: 10.1007/s40883-019-00141-2
|
14 |
Qi Zhang, Yu Lou, Xue-Li Bai, Ting-Bo Liang. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies. World Journal of Gastroenterology 2020; 26(26): 3720-3736 doi: 10.3748/wjg.v26.i26.3720
|
15 |
Sally Temraz, Rihab Nasr, Deborah Mukherji, Firas Kreidieh, Ali Shamseddine. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2022; 22(5): 507 doi: 10.1080/14737159.2022.2094706
|
16 |
Matthias Pinter, Markus Peck‐Radosavljevic. Review article: systemic treatment of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2018; 48(6): 598 doi: 10.1111/apt.14913
|
17 |
Joseph C. Ahn, Pai‐Chi Teng, Pin‐Jung Chen, Edwin Posadas, Hsian‐Rong Tseng, Shelly C. Lu, Ju Dong Yang. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Hepatology 2021; 73(1): 422 doi: 10.1002/hep.31165
|
18 |
Jumi Kang, Soon Sun Kim. Current Status and Prospects of Liquid Biopsy for Hepatocellular Carcinoma. The Korean Journal of Gastroenterology 2023; 82(1): 1 doi: 10.4166/kjg.2023.076
|
19 |
Catherine Leyh, Jason D. Coombes, Hartmut H. Schmidt, Ali Canbay, Paul P. Manka, Jan Best. MASLD-Related HCC—Update on Pathogenesis and Current Treatment Options. Journal of Personalized Medicine 2024; 14(4): 370 doi: 10.3390/jpm14040370
|
20 |
Matthias Ocker. Biomarkers for hepatocellular carcinoma: What’s new on the horizon?. World Journal of Gastroenterology 2018; 24(35): 3974-3979 doi: 10.3748/wjg.v24.i35.3974
|
21 |
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma. Journal of the Formosan Medical Association 2021; 120(8): 1581 doi: 10.1016/j.jfma.2020.11.015
|
22 |
Omkar Khade, Sagar Nagrekar, Vivek Parab, Asmita Choubey. Liquid Biopsies: As an Emerging Tool in Cancer Diagnosis and Monitoring Therapies in Metastasis. Diseases and Research 2023; 3(1): 41 doi: 10.54457/DR.202301007
|
23 |
Rosemary L. Bayless, Bethanie L. Cooper, M. Katie Sheats. Extracted Plasma Cell-Free DNA Concentrations Are Elevated in Colic Patients with Systemic Inflammation. Veterinary Sciences 2024; 11(9): 427 doi: 10.3390/vetsci11090427
|
24 |
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017
|
25 |
Yao Chen, Haifeng Xie, Ting Xie, Xunjun Yang, Yilin Pang, SongDao Ye. Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.669928
|
26 |
Robert Stawski, Dariusz Nowak, Ewelina Perdas. Cell-Free DNA: Potential Application in COVID-19 Diagnostics and Management. Viruses 2022; 14(2): 321 doi: 10.3390/v14020321
|
27 |
Ling Li, Huijia Zhao, Binyao Chen, Kang Huang, Zhuowen Hao, Zhipeng Fan, Gongpeng Sun, Jianguo Wu, Ning Li, Qifa Ye, Jiang Yue. Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/2531932
|
28 |
Filippo Pelizzaro, Romilda Cardin, Barbara Penzo, Elisa Pinto, Alessandro Vitale, Umberto Cillo, Francesco Paolo Russo, Fabio Farinati. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?. Cancers 2021; 13(9): 2274 doi: 10.3390/cancers13092274
|
29 |
Olorunseun O Ogunwobi, Trisheena Harricharran, Jeannette Huaman, Anna Galuza, Oluwatoyin Odumuwagun, Yin Tan, Grace X Ma, Minhhuyen T Nguyen. Mechanisms of hepatocellular carcinoma progression. World Journal of Gastroenterology 2019; 25(19): 2279-2293 doi: 10.3748/wjg.v25.i19.2279
|
30 |
Andrés F. Cardona, Christian Rolfo, Umberto Malapelle, Diego de Miguel-Pérez. Biopsias líquidas en cáncer: ¿estamos preparados para remplazar el tejido tumoral?. Medicina 2023; 45(4): 634 doi: 10.56050/01205498.2306
|
31 |
Kai-Qian Zhou, Yun-Fan Sun, Jian-Wen Cheng, Min Du, Yuan Ji, Peng-Xiang Wang, Bo Hu, Wei Guo, Yang Gao, Yue Yin, Jun-Feng Huang, Jian Zhou, Jia Fan, Xin-Rong Yang. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma. eBioMedicine 2020; 62: 103107 doi: 10.1016/j.ebiom.2020.103107
|
32 |
Yurika Kotoh, Yutaka Suehiro, Issei Saeki, Tomomi Hoshida, Masaki Maeda, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Yoshitaro Shindo, Yukio Tokumitsu, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki. Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma. Hepatology Communications 2020; 4(3): 461 doi: 10.1002/hep4.1469
|
33 |
Eiichiro Suzuki, Tetsuhiro Chiba, Naoya Kato. Biomarkers in Cancer Therapy. 2019; : 87 doi: 10.1007/978-981-13-7295-7_8
|
34 |
Qiong Luo, Chunming Wang, Bangjian Peng, Xiaoyu Pu, Lei Cai, Hangyu Liao, Kunling Chen, Cheng Zhang, Yuan Cheng, Mingxin Pan. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01758
|
35 |
Juan Hu, Wubo Ren, Han Liu, Cong Xie, Dandan Li, Liping Yang, Fangli Liao, Linshan Jiang, Qinli Pu, Weixian Chen. Immunomultiple PCR-based electrochemical and lateral flow strategy for the simultaneous detection of liver cancer tumor markers. Microchimica Acta 2024; 191(1) doi: 10.1007/s00604-023-06098-y
|
36 |
Guo Long, Tongdi Fang, Wenxin Su, Xingyu Mi, LeDu Zhou. The prognostic value of postoperative circulating cell-free DNA in operable hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2020; 55(12): 1441 doi: 10.1080/00365521.2020.1839127
|
37 |
Lingli Sun, Yuanlong Zhang, Wenji Zhang, Xingfei Lai, Qiuhua Li, Lingyun Zhang, Shili Sun. Green tea and black tea inhibit proliferation and migration of HepG2 cells via the PI3K/Akt and MMPs signalling pathway. Biomedicine & Pharmacotherapy 2020; 125: 109893 doi: 10.1016/j.biopha.2020.109893
|
38 |
Michihiro Kudou, Toshiyuki Kosuga, Eigo Otsuji. Artificial intelligence in gastrointestinal cancer: Recent advances and future perspectives. Artificial Intelligence in Gastroenterology 2020; 1(4): 71-85 doi: 10.35712/aig.v1.i4.71
|
39 |
Valerie Paradis, Jessica Zucman-Rossi. MacSween's Pathology of the Liver. 2024; : 96 doi: 10.1016/B978-0-7020-8228-3.00002-8
|
40 |
Marianna Alunni-Fabbroni, Kerstin Rönsch, Thomas Huber, Clemens C. Cyran, Max Seidensticker, Julia Mayerle, Maciej Pech, Bristi Basu, Chris Verslype, Julia Benckert, Peter Malfertheiner, Jens Ricke. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-2079-9
|
41 |
Bo Kong, Helmut Friess. Translational Pancreatic Cancer Research. Molecular and Translational Medicine 2020; : 97 doi: 10.1007/978-3-030-49476-6_6
|
42 |
Feifei Wei, Liang Yang, Dandan Jiang, Min Pan, Guiyan Tang, Mingyue Huang, Jing Zhang. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR‐422a/PDK2 axis. Cancer Medicine 2020; 9(7): 2480 doi: 10.1002/cam4.2861
|
43 |
Milena Peruhova, Sonya Banova-Chakarova, Dimitrina Georgieva Miteva, Tsvetelina Velikova. Genetic screening of liver cancer: State of the art. World Journal of Hepatology 2024; 16(5): 716-730 doi: 10.4254/wjh.v16.i5.716
|
44 |
Yang Zhang, Yan Yang, Yi Zhang, Zhisu Liu. lncRNA ST8SIA6‑AS1 facilitates proliferation and invasion in liver cancer by regulating miR‑142‑3p. Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10783
|
45 |
Wang Yinzhong, Wang Miaomiao, Tian Xiaoxue, Wang Qian, Qi Meng, Lei Junqiang. Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysis. Expert Review of Molecular Diagnostics 2023; 23(1): 63 doi: 10.1080/14737159.2023.2167555
|
46 |
I. F. Kustova, A. S. Makarova, N. L. Lazarevich. Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsy. Advances in molecular oncology 2019; 5(4): 8 doi: 10.17650/2313-805X-2018-5-4-8-19
|
47 |
Defeng Kong, Wen Zhang, Zhenrong Yang, Guoliang Li, Shujun Cheng, Kaitai Zhang, Lin Feng. Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis. OncoImmunology 2021; 10(1) doi: 10.1080/2162402X.2021.1938476
|
48 |
Xiaoke Wu, Mengmeng Shi, Yajun Lian, Haifeng Zhang. Exosomal circRNAs as promising liquid biopsy biomarkers for glioma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1039084
|
49 |
Ioana Manea, Razvan Iacob, Speranta Iacob, Razvan Cerban, Simona Dima, Gabriel Oniscu, Irinel Popescu, Liliana Gheorghe. Liquid biopsy for early detection of hepatocellular carcinoma. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1218705
|
50 |
Tudor Mocan, André L. Simão, Rui E. Castro, Cecília M. P. Rodrigues, Artur Słomka, Bingduo Wang, Christian Strassburg, Aliona Wöhler, Arnulf G. Willms, Miroslaw Kornek. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?. Journal of Clinical Medicine 2020; 9(5): 1541 doi: 10.3390/jcm9051541
|
51 |
Yuanwen Chen, Ping Xu, Weiqing Qiu, Hongyi Zhu, Changlin Qian, Huojian Shen, Jie Zhang. Gastric Cancer-Circulating Tumor Cells Isolation by Folic Acid Immunolipid Magnetic Beads and Clinical Application. Science of Advanced Materials 2022; 14(6): 1024 doi: 10.1166/sam.2022.4282
|
52 |
Chun Ning, Peng Cai, Xiaofan Liu, Guangtao Li, Pengfei Bao, Lu Yan, Meng Ning, Kaichen Tang, Yi Luo, Hua Guo, Yunjiu Wang, Zhuoran Wang, Lu Chen, Zhi John Lu, Jianhua Yin. A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection. eBioMedicine 2023; 93: 104645 doi: 10.1016/j.ebiom.2023.104645
|
53 |
Shucai Xie, Xili Jiang, Jianquan Zhang, Shaowei Xie, Yongyong Hua, Rui Wang, Yijun Yang. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis. PeerJ 2019; 7: e7408 doi: 10.7717/peerj.7408
|
54 |
July Rodríguez, Jenny Avila, Christian Rolfo, Alejandro Ruíz-Patiño, Alessandro Russo, Luisa Ricaurte, Camila Ordóñez-Reyes, Oscar Arrieta, Zyanya Lucia Zatarain-Barrón, Gonzalo Recondo, Andrés F. Cardona. When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review. Oncology and Therapy 2021; 9(1): 89 doi: 10.1007/s40487-021-00144-6
|
55 |
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
|
56 |
Zheyu Zhou, Xiaoliang Xu, Yang Liu, Qiaoyu Liu, Wenjie Zhang, Kun Wang, Jincheng Wang, Yin Yin. Liquid Biopsies. Methods in Molecular Biology 2023; 2695: 213 doi: 10.1007/978-1-0716-3346-5_14
|
57 |
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, Pengde Lu, Lin Xu, Hongchao Yuan, Yibin Feng, Zhe-Sheng Chen, Ning Wang. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02101-z
|
58 |
Andrea Casadei-Gardini, Orsi Giulia, Caputo Francesco, Ercolani Giorgio. Developments in predictive biomarkers for hepatocellular carcinoma therapy. Expert Review of Anticancer Therapy 2020; 20(1): 63 doi: 10.1080/14737140.2020.1712198
|
59 |
Wen-Ying Yang, Lin-Fei Feng, Xiang Meng, Ran Chen, Wen-Hua Xu, Jun Hou, Tao Xu, Lei Zhang. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes. Expert Review of Molecular Diagnostics 2020; 20(12): 1213 doi: 10.1080/14737159.2020.1855977
|
60 |
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinoma. Translational Research 2018; 201: 84 doi: 10.1016/j.trsl.2018.07.001
|
61 |
María Lola Espejo-Cruz, Sandra González-Rubio, Javier Zamora-Olaya, Víctor Amado-Torres, Rafael Alejandre, Marina Sánchez-Frías, Rubén Ciria, Manuel De la Mata, Manuel Rodríguez-Perálvarez, Gustavo Ferrín. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. International Journal of Molecular Sciences 2021; 22(23): 13073 doi: 10.3390/ijms222313073
|
62 |
Kewen He, Shaotong Zhang, Liang L. Shao, Jiani C. Yin, Xue Wu, Yang W. Shao, Shuanghu Yuan, Jinming Yu. Developing more sensitive genomic approaches to detect radioresponse in precision radiation oncology: From tissue DNA analysis to circulating tumor DNA. Cancer Letters 2020; 472: 108 doi: 10.1016/j.canlet.2019.12.004
|
63 |
Rasha Elzehery, Narmin Effat, Reham El Farahaty, Raghda Elsayed Farag, Ekbal M Abo-Hashem, Rania Elhelaly. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 158(2): 254 doi: 10.1093/ajcp/aqac037
|
64 |
Omid Gholizadeh, Hossein Bannazadeh Baghi, Mahin Ahangar Oskouee, Nader Mohammadzadeh, Behrooz Naghili, Narges Eslami, Mohsen Nasiri-toosi, Alka Hasani, Mohammad Ahngarzadeh Rezaei, Tina Taikandi, Vahdat Poortahmasebi. Comparative Transcriptional Signature Analysis of Peripheral Blood Mononuclear Cells in Early Stage of Hepatitis B-related Hepatocellular Carcinoma. Hepatitis Monthly 2023; 22(1) doi: 10.5812/hepatmon-130862
|
65 |
Shijie Li, Kerong Xin, Shen Pan, Yang Wang, Jianyi Zheng, Zeyu Li, Xuefeng Liu, Bitian Liu, Zhenqun Xu, Xiaonan Chen. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer. Cellular & Molecular Biology Letters 2023; 28(1) doi: 10.1186/s11658-023-00442-z
|
66 |
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer. ctDNA as a cancer biomarker: A broad overview. Critical Reviews in Oncology/Hematology 2020; 155: 103109 doi: 10.1016/j.critrevonc.2020.103109
|
67 |
Irun Bhan, Daniel A. Haber, Raymond T. Chung, David T. Ting. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 125 doi: 10.1007/978-3-030-21540-8_7
|
68 |
Mehrdad Ameri, Haniye Salimi, Sedigheh Eskandari, Navid Nezafat. Identification of potential biomarkers in hepatocellular carcinoma: A network-based approach. Informatics in Medicine Unlocked 2022; 28: 100864 doi: 10.1016/j.imu.2022.100864
|
69 |
Onyinye Ugonabo, Utibe-Abasi Sunday Udoh, Pradeep Kumar Rajan, Heather Reeves, Christina Arcand, Yuto Nakafuku, Tejas Joshi, Rob Finley, Sandrine V. Pierre, Juan Ramon Sanabria. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions. Biomolecules 2023; 13(9): 1369 doi: 10.3390/biom13091369
|
70 |
Francesca Carissimi, Matteo Nazzareno Barbaglia, Livia Salmi, Cristina Ciulli, Linda Roccamatisi, Giuseppe Cordaro, Venkata Ramana Mallela, Rosalba Minisini, Biagio Eugenio Leone, Matteo Donadon, Guido Torzilli, Mario Pirisi, Fabrizio Romano, Simone Famularo. Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment. World Journal of Gastrointestinal Surgery 2021; 13(9): 967-978 doi: 10.4240/wjgs.v13.i9.967
|